中盐化工(600328) - 2021 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2021 reached ¥3,399,438,180.53, representing a year-on-year increase of 38.84%[5] - Net profit attributable to shareholders was ¥436,408,040.03, a significant increase of 164.58% compared to the same period last year[5] - The net profit after deducting non-recurring gains and losses was ¥435,549,125.32, reflecting a year-on-year growth of 171.23%[5] - The basic earnings per share for the quarter was ¥0.4557, up 207.08% year-on-year[9] - Total operating revenue for the first three quarters of 2021 reached ¥9,121,332,823.29, a significant increase from ¥6,331,379,051.19 in the same period of 2020, representing an increase of approximately 44.5%[46] - Net profit for the third quarter of 2021 was ¥1,399,463,475.39, compared to ¥314,035,186.81 in the third quarter of 2020, marking an increase of about 345.5%[46] - Operating profit for the third quarter of 2021 was ¥1,695,112,129.73, up from ¥372,856,715.98 in the previous year, indicating a growth of approximately 354.5%[46] - The company reported a total comprehensive income of ¥1,399,463,475.39 for the third quarter of 2021, compared to ¥314,035,186.81 in the previous year, marking an increase of about 345.5%[48] Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥17,204,153,945.09, an increase of 28.50% from the end of the previous year[9] - As of September 30, 2021, the company's total assets reached approximately 17.20 billion RMB, an increase from 13.39 billion RMB at the end of 2020, reflecting a growth of about 28%[40] - The company reported a total asset value of ¥13,388,895,102.71 as of the end of the reporting period, slightly down from ¥13,457,276,550.78 at the end of the previous year[56] - Total liabilities increased to ¥9,203,777,775.30 in 2021 from ¥6,422,390,430.77 in 2020, representing a rise of approximately 43.8%[46] - The total liabilities amounted to ¥10,629,839,830.77, reflecting a decrease from ¥10,698,221,278.84 in the previous year[56] - The company’s total liabilities amounted to approximately CNY 6.42 billion, with current liabilities at CNY 5.63 billion and non-current liabilities at CNY 787.66 million[59] Cash Flow - Cash flow from operating activities for the year-to-date was ¥3,063,702,203.36, showing a substantial increase of 187.82% year-on-year[5] - The cash inflow from operating activities for the first three quarters of 2021 reached ¥7,174,020,243.01, a significant increase of 68.5% compared to ¥4,266,576,647.84 in the same period of 2020[52] - The net cash flow from operating activities amounted to ¥3,063,702,203.36, up from ¥1,064,445,499.53 in the previous year, representing a growth of 187.5%[52] - The total cash outflow from investing activities was ¥2,671,014,608.75, compared to ¥707,944,901.81 in the same period last year, indicating a substantial increase in investment expenditures[54] - The net cash flow from investing activities was negative at -¥2,655,098,182.40, worsening from -¥362,146,547.90 in the previous year[54] - Cash inflow from financing activities totaled ¥2,451,950,000.00, a decrease from ¥3,337,732,661.47 in the same period last year[54] - The net cash flow from financing activities was -¥39,278,803.71, compared to -¥646,444,016.70 in the previous year, showing an improvement in cash management[54] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 56,969[18] - The largest shareholder, China Salt Jilantai Salt Chemical Group Co., Ltd., holds 55.14% of the shares[18] - The company’s equity structure is being optimized through the planned share reduction by its major shareholder, which will not exceed 1% of the total share capital[32] - The total equity attributable to shareholders reached CNY 6.50 billion, while total equity was CNY 6.97 billion[61] Research and Development - R&D expenses amounted to 2,024.95 million, reflecting increased investment in research and development and team building[16] - The company plans to enhance its R&D capabilities and accelerate innovation in existing products and technologies[16] - Research and development expenses for the third quarter of 2021 totaled ¥164,488,368.18, a substantial increase from ¥7,740,810.78 in the same quarter of 2020, reflecting a growth of around 2015.5%[46] Acquisitions and Investments - The acquisition of the new business contributed positively to the overall financial performance, with significant impacts on various financial metrics[15] - The company completed the acquisition of 100% equity in Hai Investment Alkali Industry for a base price of 2,830 million[28] - The company plans to raise up to 2.8 billion RMB through a non-public offering to acquire 100% equity of a subsidiary, pending approval from the China Securities Regulatory Commission[31] - Investment income was 130.87 million, primarily due to gains from the disposal of Lan Tai Coal Industry[16] Impairment Losses - Asset impairment losses totaled 268.78 million, mainly from the provision for ineffective assets[16] - Credit impairment losses reached 559.89 million, attributed to an increase in receivables[16]